variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
ACTN2-Q9R,ACTN2,"Hypothesized to cause dilated cardiomyopathy in a dominant manner, but observations lack statistical significance.",High,Uncertain,Pathogenic,0.00056,"Heart and circulatory;Muscular, skeletal, and connective tissue;Nervous system",Dominant,Heterozygous,14567970,rs121434525,5,chr1,236849999,G,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
COL9A3-R103W,COL9A3,Carriers of this collagen variant are associated with having a significantly increased risk of lumbar disc disease (~11% total risk compared to a typical risk of 4%). ,Moderate,Likely,Pathogenic,0.048,"Muscular, skeletal, and connective tissue",Dominant,Heterozygous,11308397,rs61734651,3,chr20,61451332,T,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
BTD-D444H,BTD,"This variant is implicated in partial and profound biotinidase deficiency. Alone, this variant is estimated to have a 52% loss of enzymatic activity. This variant is often found with A171T, and together they are reported to cause profound deficiency. Notably there is a report of asymptomatic double-mutant adults, so symptoms may have variable penetrance. This variant is found compound heterozygously with more serious mutations in cases of partial biotinidase deficiency.",Low,Well-established,Pathogenic,0.03,Metabolism,Recessive,Heterozygous,88555;2109151;9375914;9654207;10206677;18704161,rs13078881,1,chr3,15686693,C,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
COL4A1-Q1334H,COL4A1,"This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.",Low,Likely,Pathogenic,0.32,Heart and circulatory,Dominant,Heterozygous,10334796;18077766;20031579,rs3742207,2,chr13,110818598,G,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
MBL2-R52C,MBL2,"This variant is associated with mannose binding protein deficiency which leads to impaired complement system immune response to mannose-rich pathogens. Patients homozygous for this allele or compound heterozygous are likely to have increased susceptibility to infection, but Hellemann et al. report heterosis for intensive care outcomes in heterozygous subjects. The wild-type version of this gene is known as variant allele A, while this is called variant allele D. See G54D (variant B) and G57E (variant C).",Low,Likely,Pathogenic,0.049,Immune system,Recessive,Heterozygous,7564730;10199352;17872904,rs5030737,1,chr10,54531242,A,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
rs5186,,"This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.",Low,Likely,Pathogenic,0.21,Drug response;Heart and circulatory,Unknown,Heterozygous,"8021009;
11250978;11593098;16046653;16675453;17668390",rs5186,2,chr3,148459988,C,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Heterozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
ATM-S49C,ATM,May be associated with a small increased risk of breast cancer.,Low,Uncertain,Pathogenic,0.01,Cancer,Complex/Other,Heterozygous,16652348;20826828,rs1800054,1,chr11,108098576,G,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
LRP5-A1330V,LRP5,"In a study of a UK population this variant was associated with a small increased risk of osteoporosis and osteoporotic bone fractures, with each copy of the variant presumed to have an additive effect. A study in Chinese young men failed to find an association with peak bone density.

 
",Low,Uncertain,Pathogenic,0.11,"Muscular, skeletal, and connective tissue",Complex/Other,Heterozygous,18455228;19148563;20953208,rs3736228,2,chr11,68201295,T,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
CLEC7A-Y238X,CLEC7A,This variant has been found to impair homan mucosal antifungal defense and was implicated in vulvovaginal candidiasis and mucocutaneous infections in a Dutch family.,Low,Uncertain,Pathogenic,0.063,Genital and urinary;Skin,Recessive,Heterozygous,19864674,rs16910526,4,chr12,10271087,C,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Heterozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
H6PD-R453Q,H6PD,"This common variant may have a small pathogenic effect by contributing to cortisone reductase deficiency (a rare abnormality) when homozygous and combined with a serious pathogenic variant. The same authors have tested and ruled out a contribution to polycystic ovary syndrome (similar phenotype, more common disease).",Low,Uncertain,Pathogenic,0.31,Genital and urinary;Metabolism,Recessive,Heterozygous,12858176;15827106;16817821,rs6688832,1,chr1,9323910,A,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
rs1544410,,"rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ",Low,Uncertain,Pharmacogenetic,0.35,Other,Unknown,Heterozygous,,rs1544410,0,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
ABCC6-R1268Q,ABCC6,This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.,Low,Uncertain,Pharmacogenetic,0.22,Metabolism,Unknown,Homozygous,10811882;10913334;11776382;20038957,rs2238472,1,chr16,16251599,T,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Heterozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Homozygous,18236005;19081515,rs1799990,0,chr20,4680251,G,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
CCR5-S185Shift,CCR5,"Also known as CCR5-delta32, this variant is associated with resistance to many strains of HIV (but not all strains, only strains that use target the CCR5 protein). Heterozygotes are reported to have slower HIV progression, and homozygotes are very resistant to being infected by these strains.",Low,Well-established,Protective,0.048,Immune system,Recessive,Heterozygous,8751444;8791590;8898752,rs333,1,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Homozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Heterozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
IL7R-T244I,IL7R,"The reference genome variant for this allele has been associated with a slight increased risk of multiple sclerosis. Thus, this variant can be treated as a ""protective"" variant -- carriers of this variant are slightly less likely to have MS. Because the disease is rare and the effect of this variant is not very strong, the absolute decreased risk for carriers of this variant is less than .05% (less than 1 in 2000).",Low,Likely,Protective,0.21,Immune system;Nervous system,Unknown,Homozygous,12825072;17660530;17660816;17660817;21161391,rs6897932,0,chr5,35874575,T,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
LPL-S474X,LPL,"This variant actually increases LPL enzyme activity despite creating a termination codon (see Rip J et al). It appears to be a protective variant, associated with lower triglyceride levels--although the effect is quite weak and explains only 0.5-1% of triglyceride variation.",Low,Uncertain,Protective,0.084,Metabolism,Unknown,Heterozygous,16574898;17463246;18193044;19802338;20429872;22042884,rs328,,chr8,19819724,G,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
TYR-R402Q,TYR,"This is a frequent pigmentation polymorphism in Europeans that affects function of the Tyrosinase gene. It is associated with blue instead of green eyes and sun sensitivity. For the most part this variant is benign, but many individuals with ocular albinism (which affects only the eyes) carry this variant along with another more severe variant in the same gene.",Low,Well-established,Benign,0.2,Hearing and vision,Complex/Other,Heterozygous,1820207;7704033;11284711;18326704;18488027;18488028;19533789,rs1126809,0,chr11,89017961,A,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
OCA2-R305W,OCA2,"This variant is associated with eye color, as is OCA2 Arg419Gln. Individuals with this variant are more likely to have brown/black eyes (as opposed to blue/gray or green/hazel). Other variants in this gene are associated with oculocutaneous albinism (albinism which involves skin and eyes).",Low,Likely,Benign,0.082,Hearing and vision;Skin,Unknown,Heterozygous,"12163334;
15889046",rs1800401,,chr15,28260053,A,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
COL6A3-D2831H,COL6A3,"Probably benign, reported by Pan et al. as a presumed-nonpathogenic variant in the gene.",Low,Likely,Benign,0.068,Other,Unknown,Heterozygous,9536084;15563506,rs36104025,,chr2,238247734,G,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
NEFL-S472Shift,NEFL,"Although a frameshift in this gene would be predicted to cause Charcot-Marie Neuropathy, this particular position appears to reflect a single base insertion error/mutation in the reference genome (in other words, normal individuals are always homozygous for a deletion at this position relative to reference). See chr8:24,811,060-24,811,080 annotations on UCSC.",Low,Likely,Benign,,Nervous system,Unknown,Homozygous,,rs11340767,,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
KEL-T193M,KEL,This variant is also known as Kell or K1 or K (capitalized) in the Kell antigen system. K1-negative mothers (carrying no copies of this variant) carrying K1-positive fetuses (heterozygous or homozygous) are at risk for hemolytic disease of the newborn. About 9% of caucasians carry one or two copies of K1.,Low,Uncertain,Benign,0.032,Blood,Dominant,Heterozygous,7849312,rs8176058,,chr7,142655008,A,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
ERCC6-R1230P,ERCC6,Probably benign.,Low,Uncertain,Benign,0.07,Other,Unknown,Heterozygous,,rs4253211,,chr10,50678317,G,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
COL5A2-P460S,COL5A2,"Tentatively benign. Although predicted to be damaging by Polyphen 2, this variant is seen in 2 out of 62 PGP & public genomes. OMIM lists other more disruptive variants (frameshift & nonsense) as reported to cause Ehlers-Danlos syndrome when homozygous.",Low,Uncertain,Benign,0.04,"Muscular, skeletal, and connective tissue",Unknown,Heterozygous,,rs35830636,,chr2,189932764,A,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
MAPT-Q230R,MAPT,Common polymorphism.,Low,Uncertain,Benign,0.042,Other,Unknown,Heterozygous,15365985,rs63750072,,chr17,44060859,G,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
PKP2-L366P,PKP2,This variant is a benign polymorphism.  ,Low,Uncertain,Benign,0.22,Other,Unknown,Homozygous,19955750,rs1046116,,chr12,33021934,G,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
NTRK1-G613V,NTRK1,"Also called G607V, this variant has been reported as a nonpathogenic polymorphism.",Low,Uncertain,Benign,0.043,Other,Unknown,Heterozygous,10330344;10443680;11159935,rs6339,,chr1,156848946,T,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
NTRK1-H604Y,NTRK1,"Various databases and papers treat this variant as a non-pathogenic polymorphism, although it is fairly uncommon and is computational methods predict it to be damaging.",Low,Uncertain,Benign,0.043,Other,Unknown,Heterozygous,10443680;16412461;21228398,rs6336,,chr1,156848918,T,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
MAPT-R370W,MAPT,Probably benign.,Low,Uncertain,Benign,0.16,Other,Unknown,Heterozygous,15365985,rs17651549,,chr17,44061278,T,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
ABCC11-G180R,ABCC11,This variant is associated with dry type ear wax (a benign trait) in a recessive manner.,Low,Uncertain,Benign,0.098,Other,Unknown,Homozygous,14471313;16444273,rs17822931,,chr16,48258198,T,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
PTCH1-P1315L,PTCH1,"Common polymorphism, presumed benign.",Low,Uncertain,Benign,0.3,Other,Unknown,Heterozygous,15712338,rs357564,,chr9,98209594,A,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Heterozygous,17952075;17999355,rs1042602,,chr11,88911696,A,http://evidence.pgp-hms.org/genomes?display_genome_id=75958d26989d7433f0dae280d4e7a983c53957a4&access_token=68ee26a29f2f0687bd92fc96d4636d42
